scanance.
Sign inGet Premium
SB

SBC Medical Group Holdings Incorporated

SBCIndustrialsNASDAQ

Consulting Services

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$173.6M
-15.5% YoY
Net Income
$51.0M
+9.4% YoY
EBITDA
$84.9M
+9.9% YoY
Free Cash Flow
$55.7M

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About SBC Medical Group Holdings Incorporated

Headquartered within the industrials sector, SBC Medical Group Holdings Incorporated focuses on Consulting Services services and products. SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company carries a $329.1M market cap, placing it firmly in the small-cap category. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement.

Key stats
Market Cap$329.1M
P/E (TTM)8.00
Fwd P/E6.60
EPS$0.40
Beta0.61
52W Change-34.0%
ROE16.5%
Analysis

The balance sheet looks solid with $167.6M in cash comfortably exceeding the $51.9M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Annual free cash flow of $55.7M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 16.5% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 11.3% further supports the picture of efficient asset utilization. Revenue has been relatively flat, moving from $174.2M (2022) to $173.6M (2025).

SBC's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. No single metric tells the full story. Reviewing SBC's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms